Crop Life Science Limited’s upcoming initial public offering (IPO). Here’s a breakdown of the key details:
- IPO Pricing: The IPO is priced at Rs 52 per share. This is the price at which investors can purchase shares during the IPO.
- IPO Dates: The IPO commenced on August 18 and the bidding period for the offer will conclude on August 22. During this time, investors have the opportunity to place their bids for the shares.
- Objective: Crop Life Science Limited aims to secure Rs 26.73 crore through the issuance of fresh shares. This capital could be utilized for various purposes such as business expansion, research and development, working capital, and other corporate requirements.
- Listing Platform: The company’s shares are expected to be listed on the NSE EMERGE platform on August 30. NSE EMERGE is a platform provided by the National Stock Exchange of India (NSE) for the listing of small and medium-sized enterprises (SMEs).
Crop Life Science Limited places a strong emphasis on intellectual property protection and branding. The company’s extensive trademark portfolio and branding efforts suggest a commitment to building a strong identity and reputation in the market.
Crop Life Science Limited’s strong emphasis on intellectual property protection, coupled with its financial performance details, provides a comprehensive view of the company’s operations and growth.
Let’s break down the key points you’ve provided:
- Intellectual Property Protection:
- Copyrights: The company holds eight registered copyrights under the Copyrights Act. Copyrights protect original literary, artistic, and creative works, indicating that the company places importance on safeguarding its intellectual property assets beyond just trademarks.
- Design Registration: The registration of the bottle design under the Designs Act and Rules signifies the company’s focus on protecting the unique design of its products. Design registrations offer legal protection against unauthorized copying or imitation of product designs.
- Patents: Crop Life Science possesses four registered patents, which suggests that the company has developed innovative technologies or processes that are protected by patent rights. Additionally, the submission of four patent applications indicates ongoing research and development efforts.
- Financial Performance:
- Revenue: For the financial period ending on February 18, 2023, the company reported a revenue of Rs 122.54 crore. This marks an increase compared to the previous fiscal year, indicating growth in the company’s business operations.
- Net Profit: Crop Life Science reported a net profit of Rs 4.37 crore for the same financial period. The net profit signifies the company’s ability to generate earnings after accounting for all expenses.
- Borrowing: The total borrowing during the period was Rs 26.82 crore, which suggests the company’s financing activities to support its operations and growth initiatives.
- Year-on-Year Comparison:
- In the financial year 2022, the company’s revenue was Rs 102 crore, which is slightly lower than the previous year’s revenue of Rs 118.93 crore. This decline could be attributed to various factors affecting the industry or the company’s operations.
- The net profit for the fiscal year 2022 was Rs 2.81 crore, compared to Rs 3.7 crore in the preceding year. This variation in net profit reflects the company’s profitability performance over the years.
